Vagus nerve stimulation and magnet use: Optimizing benefits

Epilepsy and Behavior

Volumn 15, Issue 3, 2009, Pages 299-302

  Tatum IV, William O ^a,b   Helmers, Sandra L ^c  

^a TAMPA GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; Neurostimulation; Protocol; Seizure; Vagus nerve stimulation

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE SEVERITY; ELECTRIC CURRENT; ELECTROSTIMULATION THERAPY; EPILEPSY; EPILEPTIC STATE; FOCAL EPILEPSY; FREQUENCY MODULATION; HUMAN; INTRACTABLE EPILEPSY; MAGNET; MAGNETIC FIELD; MAGNETIC STIMULATION; MAGNETISM; MEDICAL INSTRUMENTATION; MORBIDITY; PATIENT CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

ELECTRIC STIMULATION; EPILEPSY; HUMANS; MAGNETICS; VAGUS NERVE STIMULATION;

EID: 67650461969     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.04.002     Document Type: Article

References (16)

1. Zabara J. Time course at seizure control to brief, repetitive stimuli [abstract]. Epilepsia 26 Suppl. 5 (1985) S518
2. Morris III G.L. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy Behav 4 (2003) 740-745
3. Cyberonics, Inc, Epilepsy Physician's Manual. http://www.vnstherapy.com/epilepsy/hcp/manuals/default.aspx. Accessed: September 25, 2008.
4. Jandial R., Aryan H.E., Hughes S.A., and Levy M.L. Effect of vagus nerve stimulator magnet on programmable shunt settings. Neurosurgery 55 (2004) 627-629 [Discussion 629-30]
5. Guilfoyle M.R., Fernandes H., and Price S. In vivo alteration of Strata valve setting by vagus nerve stimulator-activating magnet. Br J Neurosurg 21 (2007) 41-42
6. Heck C., Helmers S.L., and DeGiorgio C.M. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 59 Suppl. 4 (2002) S31-S37 6
7. Sirven J.I., Sperling M.R., French J.A., and O'Connor M.J. Significance of simple partial seizures in temporal lobe epilepsy. Epilepsia 37 (1996) 450-454
8. Towne A.R., Pellock J.M., Ko D., and DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 35 (1994) 27-34
9. Tatum W.O., French J.A., Benbadis S.R., and Kaplan P.W. The etiology and diagnosis of status epilepticus. Epilepsy Behav 2 (2001) 311-317
10. Tatum W.O., Johnson K.D., Goff S., Ferreira J., Benbadis S.R., and Vale F. Vagus nerve stimulation and drug reduction. Neurology 56 (2001) 561-563
11. Andriola M.R., and Vitale S.A. Vagus nerve stimulation in the developmentally disabled. Epilepsy Behav 2 (2001) 129-134
12. Boon P., Vonck K., Van Walleghem P., et al. Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol 18 (2001) 402-407
13. Murphy J.V., and Patil A. Stimulation of the nervous system for the management of seizures: current and future developments. CNS Drugs 17 (2003) 101-115
14. McHugh J.C., Singh H.W., Phillips J., Murphy K., Doherty C.P., and Delanty N. Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification. Epilepsia. 48 (2007) 375-378
15. Major P., and Thiele E.A. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 13 (2008) 357-360
16. DeGiorgio C.M., Thompson J., Lewis P., et al. Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term XE5 study. Epilepsia 42 (2001) 1017-1020